Search Results - "Otsu, Kae"

One‐hour oral glucose tolerance test plasma glucose at gestational diabetes diagnosis is a common predictor of the need for insulin therapy in pregnancy and postpartum impaired glucose tolerance by Nishikawa, Takeshi, Ono, Keiko, Hashimoto, Shoko, Kinoshita, Hiroyuki, Watanabe, Takuro, Araki, Hirotaka, Otsu, Kae, Sakamoto, Wakana, Harada, Masahiro, Toyonaga, Tetsushi, Kawakami, Shoichi, Fukuda, Jyunichiro, Haga, Yoshio, Kukidome, Daisuke, Takahashi, Takeshi, Araki, Eiich

“…Aims/Introduction Gestational diabetes mellitus (GDM) is a risk for adverse perinatal outcomes, and patients with a history of GDM have an increased risk of…”
Get full text

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study by Shimoda, Seiya, Sakamoto, Wakana, Hokamura, Ayaka, Matsuo, Yasuto, Sekigami, Taiji, Ichimori, Shinji, Iwashita, Shinsuke, Ishii, Norio, Otsu, Kae, Yoshimura, Ryohei, Nishiyama, Toshihiko, Sakaguchi, Masaji, Nishida, Kenro, Araki, Eiichi

“…To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs (insulin…”
Get full text

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naive Japanese adults with type 2 diabetes : a pilot, randomized, controlled study by Seiya Shimoda, Wakana Sakamoto, Ayaka Hokamura, Yasuto Matsuo, Taiji Sekigami, Shinji Ichimori, Shinsuke Iwashita, Norio Ishii, Kae Otsu, Ryohei Yoshimura, Toshihiko Nishiyama, Masaji Sakaguchi, Kenro Nishida, Eiichi Araki

“…Abstract. To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs…”
Get full text

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study by Shimoda, Seiya, Sakamoto, Wakana, Hokamura, Ayaka, Matsuo, Yasuto, Sekigami, Taiji, Ichimori, Shinji, Iwashita, Shinsuke, Ishii, Norio, Otsu, Kae, Yoshimura, Ryohei, Nishiyama, Toshihiko, Sakaguchi, Masaji, Nishida, Kenro, Araki, Eiichi

“…To examine the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) or once-daily second-generation basal insulin analogs (insulin…”
Get full text

A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study) by Shimoda, Seiya, Sato, Miki, Sekigami, Taiji, Motoshima, Hiroyuki, Yoshimura, Ryohei, Fukuda, Kazuki, Matsuo, Yasuto, Noda, Hideyuki, Okubo, Mina, Ichimori, Shinji, Fujisawa, Kazuo, Fukunaga, Makiko, Araki, Eiichi, Nishikawa, Takeshi, Furukawa, Noboru, Matsumura, Takeshi, Kondo, Tatsuya, Kawashima, Junji, Senokuchi, Takafumi, Igata, Motoyuki, Nishida, Kenro, Yano, Tomohiko, Taguchi, Tetsuya, Matsuda, Hirofumi, Tsuruzoe, Kaku, Hirashima, Yoshiaki, Kaneko, Kengo, Kitanao, Sayaka, Hazekawa, Iwaho, Ebihara, Kenji, Murata, Yusuke, Watanabe, Eiichiro, Ishii, Norio, Nishioka, Hiroko, Horio, Kaori, Furusho, Masatsugu, Ikema, Michiko, Otsu, Kae, Yano, Tomomi, Shirao, Tomohiro, Matsuyama, Rina, Nishiyama, Toshihiko, Matsuyoshi, Akiko, Takeda, Haruo, Kasho, Masaya, Tsutsumi, Etsuro, Ono, Kaoru

“…Aims/Introduction The aim of the present prospective observational study was to assess long‐term efficacy and safety of insulin degludec as a part of a…”
Get full text